An Empirical Examination of the Current State of Publically Available Nanotechnology Guidance Materials

Lane N. and Kalil T. , “The National Nanotechnology Initiative: Present at the Creation,” Issues in Science and Technology 21, no. 4 (2005): 49–54.

Lux Research, The Nanotech Report: Investment Overview and Market Research for Nanotechnology, 5th ed., 2007, at 1.

National Institute for Occupational Safety and Health, “Nanotechnology,” available at <http://www.cdc.gov/niosh/topics/nanotech/faq.html> (last visited October 24, 2012).

Fatehi L. , “Recommendations for Nanomedicine Human Subjects Research Oversight: An Evolutionary Approach for an Emerging Field,” Journal of Law, Medicine & Ethics 40, no. 4 (2012): 716–750; see also <http://www.eeb.org/?LinkServID=5403FF15-9988-45A3-0E327CBA2AFD88BA&showMeta=0&aa> (last visited November 5, 2012).

U.S. Department of Health and Human Services, “Code of Federal Regulations,” available at <http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.html#subparta> (last visited October 24, 2012).

Colvin V. L. , “The potential environment impact of engineered nanomaterials,” Nature Biotechnology 21, no. 10 (2003): 1166–1170.

Oberdörster G. Oberdörster E. , and Oberdörster J. , “Nanotoxicity: An Emerging Discipline Evolving from Studies of Ultrafine Particle,” Environmental Health Perspectives 113, no. 7 (2005): 823–839.

Id.

National Research Council (NRC), Committee to Develop a Research Strategy for Environmental, Health, and Safety Aspects of Engineered Nanomaterial, A Research Strategy for Environmental, Health, and Safety Aspects of Engineered Nanomaterials (Washington, D.C.: The National Academies Press, 2012).

Resnik D. B. and Tinkle S. S. , “Ethical Issues in Clinical Trials Involving Nanomedicine,” Contemporary Clinical Trials 28, no. 4 (2007): 433–441; Warheit D. B. , “Debunking Some Misconceptions About Nanotoxicology,” Nano Letters 10, no. 12 (2010): 4777–4782; Joffe S. and Miller F. G. , “Bench to Bedside: Mapping the Moral Terrain of Clinical Research,” Hastings Center Report 38, no. 2 (2008): 30–42.

Marchant G. E. Sylvester D. J. , and Abbott K. W. , Risk Management Principles for Nanotechnology, available at <http://www.law.upenn.edu/academics/institutes/regulation/papers/MarchantRiskManagementPrinciples.pdf> (last visited October 24, 2012).

University of California-Berkeley, “Finding Information on the Internet: A Tutorial,” available at <http://www.lib.berkeley.edu/TeachingLib/Guides/Internet/FindInfo.html> (last visited October 24, 2012).

Wise A. R. Schwartz J. , and Woodruff T. J. , “A Nanotechnology Policy Framework for California: Policy Recommendations for Addressing Potential Health Risks From Nanomaterials,” available at <http://www.prhe.ucsf.edu/prhe/nanoreport-DRAFT.pdf> (last visited October 24, 2012).

European Environmental Bureau, EEB Position Paper on Nanotechnologies and Nanomaterials, February 2009, available at <http://www.eeb.org/publication/2009/090228_EEB_nano_position_paper.pdfwww.eeb.org/publication/2009/090228_EEB_nano_position_paper.pdf> (last visited April 30, 2012).

University of Minnesota: Center for Science, Technology, and Public Policy, The Nanotechnology-Biology Interface: Exploring Models for Oversight, September 2005, available at <http://www.hhh.umn.edu/img/assets/9685/nanotech_jan06.pdf> (last visited October 24, 2012).

European Commission, Nanotechnology and the Health of the EU Citizen in 2020, European and International Forum on Nanotechnology, Edinburgh, United Kingdom, September 5–9, 2005, available at <http://www.euronanoforum2005.org/proceedings/euronanoforum2005_proceedings.pdf> (last visited October 24, 2012).

See European Environmental Bureau, supra note 14.

University of California, San Diego, “Nanotechnology: Guidelines for Safe Research Practices,” available at <http://blink.ucsd.edu/safety/research-lab/nanotechnology.html> (last visited October 24, 2012).